- No posts yet.
- Proteome expansion and subsequent reproducibility crisis define a year of structural recalibration in metaproteomics. 365-day briefing • 2025-07-28 - 2026-07-27
- Metabolite glues and diet-driven tumorigenesis highlight new mechanisms in microbiome and metabolism research 7-day briefing • 2026-07-15 - 2026-07-21
- Obesogenic diet and gut microbiome synergistically enhance anti-PD-1 efficacy via Lactobacillus johnsonii metabolites 7-day briefing • 2026-07-08 - 2026-07-14
- Spatial human proteome map across tissues and cancers published; microbiome benchmarking shows reproducibility gaps 7-day briefing • 2026-06-17 - 2026-06-23
- Gut microbial acetylcholine from dietary choline enhances mucosal immunity, Nature study reveals. 7-day briefing • 2026-06-03 - 2026-06-09
- Multi-species transcriptomic clocks and metabolic axes dominate a week of high-impact omics studies. 7-day briefing • 2026-05-27 - 2026-06-02
- Proteome expansion via non-canonical ORFs solidifies as the year's defining structural shift, with ~1,700 new microproteins and peptideins identified. 365-day briefing • 2025-05-27 - 2026-05-26
- Proteome expansion via non-canonical ORFs emerges as quarterly defining shift, with ~1,700 new microproteins and peptideins 90-day briefing • 2026-02-26 - 2026-05-26
- Proteome expansion via ncORF translation emerges as sustained theme across limited window 30-day briefing • 2026-04-27 - 2026-05-26
- Large-scale proteomics identifies ~1,700 new microproteins from non-canonical ORFs, expanding the human proteome 7-day briefing • 2026-05-20 - 2026-05-26
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Meeting ir.neogenomics.com | 62d ago
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Covering MRD, NGS, and Real-World Evidence ir.neogenomics.com | 62d ago
- NeoGenomics makes oncology test portfolio available through Epic Aura ir.neogenomics.com | 95d ago
- NeoGenomics Makes Oncology Test Ordering Available Through Epic Aura EHR Integration ir.neogenomics.com | 95d ago
- NeoGenomics launches RaDaR ST ctDNA assay for molecular residual disease detection across solid tumor types ir.neogenomics.com | 152d ago
- NeoGenomics Launches RaDaR ST for Molecular Residual Disease Detection in Solid Tumors ir.neogenomics.com | 152d ago
- NeoGenomics launches PanTracer LBx liquid biopsy CGP test for advanced solid tumors ir.neogenomics.com | 362d ago
- NeoGenomics Launches PanTracer LBx, a Liquid Biopsy Comprehensive Genomic Profiling Test ir.neogenomics.com | 362d ago
- NeoGenomics Launches PanTracer Tissue and PanTracer Tissue HRD Assays ir.neogenomics.com | 392d ago
- NeoGenomics launches PanTracer Tissue and PanTracer Tissue HRD for advanced cancer diagnostics ir.neogenomics.com | 392d ago
Showing page 1 of 2
(28 total results)
← Prev
Next →